DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell ...
A new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID ...
ATLANTA – In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 ...
Cardamom seed extract enhances the body’s innate immune defense by stimulating the production of antiviral molecules.
Type 1 interferons (IFNs) play a central role in the development and disease course of systemic lupus erythematosus (SLE). In a new study, researchers explored SLE disease activity and type I ...
BOSTON--(BUSINESS WIRE)--ROME Therapeutics, a biotechnology company harnessing the power of the dark genome to develop breakthrough medicines for serious diseases, announced new data validating the ...
AstraZeneca has received the green light from European regulators for its Saphnelo treatment for lupus, the pharma giant ...
Novel biomarkers are being discovered using TISSUEFAXS CHROMA and StrataQuest image analysis solution, with promising candidates used for predicting a patient’s response to neoadjuvant treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback